CEI Subsidiary, Viking Energy Group (OTC: VKIN) Leads Pack In Sustainable Medical Waste Treatment Technology

(NewsDirect)

The amount of medical
waste needing to be managed is growing. An increase in the prevalence
of illnesses such as COVID-19, a growing medical infrastructure, and
an increasing population are all factors contributing to the growing
amount of medical waste.

These three factors combine to create a growing market for
companies that deal with treating medical waste. According to industry
analyst Grand View Research, the global medical waste management
market was valued at $21.0 billion in 2016 and is predicted to grow at
a CAGR of 5.4% through 2025.

According to the World Health Organization,
managing healthcare waste requires increased attention and diligence
to avoid negative health and environmental outcomes.

Key elements of
improving the management of medical waste, according to the WHO,
involve favoring the safety of workers involved and putting an
emphasis on being environmentally sound.

In this article, we will focus on Camber
Energy Inc’s (NYSEAmerican: CEI) majority-controlled subsidiary,
Viking Energy Group Inc., and how their game-changing technology seeks
to alter the medical waste market.

Viking Energy Group Inc. (OTC: VKIN)

is a
growth-oriented, diversified energy company, majority controlled by
Camber Energy Inc. Through various majority-owned subsidiaries, Viking
provides custom energy and power solutions to commercial and
industrial clients in North America and owns interests in oil and
natural gas assets in the United States. The company also holds an
exclusive license in Canada for a patented carbon capture system.

Through its
majority-owned subsidiary, Viking Ozone Technology, LLC, VKIN offers
its revolutionary VKIN-6000, a waste treatment system utilizing ozone.
By combining their technology with the use of ozone, VKIN is able to
offer an environmentally sustainable and cost-effective solution.

Current medical
and biohazardous waste management solutions that VKIN targets to
replace include incineration, chemical treatment, autoclaves, and heat
treatments. Each of these current methods has multiple drawbacks.
These methods for treating medical waste tend to be dangerous for
workers, involve the burning of harmful and odorous gasses, and result
in the release of harmful chemicals into the environment.

The VKIN-6000 eliminates
the heating element of treating medical waste. This means VKIN’s
solution dramatically reduces the amount of energy used during the
process, lowering costs, conserving resources, and eliminating
greenhouse gases. This results in a cheaper process that is safer and
more environmentally friendly.

Waste that has been treated by the VKIN-6000 is
able to be turned into a renewable resource, further proving its
environmentally friendly capabilities.

Recently, VKIN received a Notice of Allowance
from the United States Patent & Trademark Office (“USPTO”)
for patent application No. 17/576,801 titled “Multi-Chamber
Medical Waste Ozone-Based Treatment Systems and Methods”. A Notice
of Allowance means that the USPTO has made the determination that a
patent will be granted from an application. This means their
game-changing medical waste technology should receive a patent in the
coming months.

The need for a solution that treats medical waste in a way that
is safe for the environment and for the workers involved in the
process is clear. VKIN offers that with their groundbreaking ozone
treatment technology. With the amount of medical and biohazardous
waste growing with the population, look to solutions like the
VKIN-6000 to be the way of the future.

Keep VKIN on your radar for stocks in the
medical waste sector to watch.

For
more information investors should visit:

https://ir.vikingenergygroup.com/

Disclaimers:
The Private Securities Litigation Reform Act of 1995 provides
investors a safe harbor in regard to forward-looking statements. Any
statements that express or involve discussions with respect to
predictions, expectations, beliefs, plans, projections, objectives,
goals, assumptions or future events or performance are not statements
of historical fact may be forward looking statements. Forward looking
statements are based on expectations, estimates, and projections at
the time the statements are made that involve a number of risks and
uncertainties which could cause actual results or events to differ
materially from those presently anticipated. Forward looking
statements in this action may be identified through use of words such
as projects, foresee, expects, will, anticipates, estimates, believes,
understands, or that by statements indicating certain actions &
quote; may, could, or might occur. Understand there is no guarantee
past performance will be indicative of future results. Investing in
micro-cap and growth securities is highly speculative and carries an
extremely high degree of risk. It is possible that an investors
investment may be lost or impaired due to the speculative nature of
the companies profiled. RazorPitch is responsible for the production
and distribution of this content. RazorPitch is not operated by a
licensed broker, a dealer, or a registered investment adviser. It
should be expressly understood that under no circumstances does any
information published herein represent a recommendation to buy or sell
a security. RazorPitch authors, contributors, or its agents, may be
compensated for preparing research, video graphics, and editorial
content. RazorPitch has been compensated three thousand five hundred
via wire transfer by Regal Consulting to produce and syndicate content
related to VKIN. As part of that content, readers, subscribers, and
website viewers, are expected to read the full disclaimers and
financial disclosures statement that can be found on our
website.